Rheumatoid arthritis (RA) responds best to a combination of medication, exercise, diet, and joint protection strategies started as early as possible. The goal of modern treatment is remission or near-remission, not just pain relief. Most people with RA can reach low disease activity with the right combination of approaches, but the key is acting quickly and adjusting treatment until it works.
Why Early, Aggressive Treatment Matters
RA causes permanent joint damage when inflammation goes unchecked, and most of that damage happens in the first two years. Current guidelines from the American College of Rheumatology strongly recommend a “treat-to-target” approach: setting a specific goal (usually remission or low disease activity), checking progress regularly, and changing treatment if you’re not hitting that goal. This strategy consistently outperforms a wait-and-see approach. If one medication isn’t working well enough, your treatment should be adjusted rather than simply continued at the same level.
Methotrexate: The First-Line Treatment
Methotrexate is the standard first medication for RA because it’s effective, well-studied, and relatively affordable. It works by dampening the overactive immune response that drives joint inflammation. Most people start on a weekly dose and gradually increase over months until the disease is controlled or they reach the highest dose they can tolerate comfortably.
One important addition: folic acid supplements taken alongside methotrexate significantly reduce side effects like nausea and liver irritation without making the drug less effective. A meta-analysis of nine clinical trials confirmed this benefit. If you’re on methotrexate and experiencing stomach problems, folic acid supplementation is one of the first things to discuss.
Some people don’t respond well enough to methotrexate taken as a pill. In those cases, switching to an injectable form can improve absorption and effectiveness before moving on to a different drug entirely.
Biologic and Targeted Therapies
When methotrexate alone isn’t enough, the next step is typically adding a biologic or a targeted oral therapy. These drugs zero in on specific parts of the immune system that fuel RA inflammation.
The two most established biologic classes work differently. One group blocks a protein called TNF, which is a major driver of joint inflammation. The other blocks a different inflammatory signal called IL-6. In head-to-head trials of patients who hadn’t responded to methotrexate, IL-6 blockers performed better than TNF blockers when used alone (without methotrexate). Both classes work well when combined with methotrexate.
A newer option is JAK inhibitors, which are oral medications that interrupt inflammatory signaling inside immune cells. Clinical trials and real-world data show they work about as well as biologics for most patients. However, one large safety trial found that patients over 50 with existing heart disease risk factors had higher rates of cardiovascular events and cancer on one JAK inhibitor compared to TNF blockers. For younger patients without those risk factors, JAK inhibitors remain a reasonable option.
If your first biologic or targeted therapy doesn’t work, guidelines recommend switching to a drug from a different class rather than trying another one in the same category. For example, if a TNF blocker fails, moving to an IL-6 blocker or JAK inhibitor is preferred over trying a second TNF blocker.
Strength Training and Exercise
Many people with RA avoid exercise out of fear that it will damage their joints. Research consistently shows the opposite. Moderate to high-intensity strength training improves muscle strength without increasing disease activity or pain. Stronger muscles better support and protect inflamed joints, reducing the mechanical stress on them during daily activities.
Low-intensity programs produce smaller gains than moderate or high-intensity ones, so pushing yourself (within your tolerance) pays off. The catch is consistency: the benefits disappear if you stop. Aim for regular sessions rather than occasional bursts. Swimming, cycling, and walking are also well-tolerated and help maintain cardiovascular fitness and joint mobility.
Joint Protection and Assistive Devices
Occupational therapy offers some of the most practical, day-to-day help for RA. Two high-quality studies found that people who received instruction on joint protection techniques performed daily tasks significantly better than those who didn’t, with functional improvements of 17 to 22 percent.
Joint protection means learning to use your larger, stronger joints instead of smaller ones (carrying bags on your forearm instead of gripping with your fingers), spreading the load across multiple joints, and avoiding positions that push joints toward deformity. Assistive devices like jar openers, built-up handles on utensils, and long-handled reachers reduce strain during routine tasks. Splints, particularly for the wrists and hands, can reduce pain by about 19 percent by keeping inflamed joints in a stable position.
Diet: The Mediterranean Approach
Among dietary patterns studied for RA, the Mediterranean diet has the most evidence. A systematic review of human studies found that people with RA who followed a Mediterranean diet (rich in fish, olive oil, vegetables, fruits, nuts, and whole grains) reported significantly less pain and better physical function compared to control groups. One trial also showed a meaningful reduction in overall disease activity scores.
The Mediterranean diet is naturally high in omega-3 fatty acids from fish, and omega-3 supplements on their own have shown clinical benefit. A 12-month trial found that patients taking 2.6 grams of omega-3s daily had significant improvements in both their own assessment and their doctor’s assessment of pain. The lower dose of 1.3 grams didn’t produce the same effect, so the amount matters. Look for supplements listing their combined EPA and DHA content, and aim for at least 2.5 grams total per day.
Curcumin Supplements
Curcumin, the active compound in turmeric, has genuine anti-inflammatory properties. A meta-analysis of multiple clinical trials found that curcumin supplements significantly reduced two key markers of inflammation in RA patients: C-reactive protein (CRP) dropped meaningfully, and erythrocyte sedimentation rate (a measure of how much inflammation is present in the body) also improved. Trials typically used doses ranging from 500 mg to 1,200 mg daily over 8 to 12 weeks.
Curcumin is poorly absorbed on its own. Many trial formulations used enhanced versions like nanomicelles or combined curcumin with black pepper extract to improve absorption. A standard turmeric capsule from the grocery store may not deliver the same results as the formulations tested in clinical trials. Curcumin can complement RA medications, but it isn’t potent enough to replace them.
Putting It Together
The most effective approach to RA stacks multiple strategies. Medication controls the underlying immune dysfunction. Exercise builds the muscle support your joints need. Joint protection techniques and assistive devices reduce daily wear. An anti-inflammatory diet and targeted supplements like omega-3s provide a modest but real additional benefit. None of these approaches works as well alone as they do in combination, and none of the lifestyle measures replace the need for disease-modifying medication in active RA. The earlier you start building this combination, the more joint function you preserve long-term.

